Neurodynamic Sliders Promote Flexibility in Tight Hamstring Syndrome

Sponsor
University Ghent (Other)
Overall Status
Completed
CT.gov ID
NCT05652452
Collaborator
(none)
50
2
17.9

Study Details

Study Description

Brief Summary

The goal of this study is to explore the intervention effect of home-based neurodynamic slider program on hamstring flexibility. Fifty physically active male subjects will be randomly assigned to either performing a neurodynamic sliding technique (3x20 reps) or a static stretching protocol (3x30") on a daily basis for a 6-week period. Hamstring flexibility will be assessed by means of the Straight Leg Raise at baseline, immediately after the intervention and after 4 weeks follow up.

Condition or Disease Intervention/Treatment Phase
  • Other: Neurodynamics
  • Other: Static stretch
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Neurodynamic Sliders Promote Flexibility in Tight Hamstring Syndrome
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Jul 1, 2017
Actual Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neurodynamics

Other: Neurodynamics
Subjects in the neurodynamic group performed the 'Seated Straight Leg Slider' (SSLS) (Fig.1). To execute this sliding technique, subjects assumed a seated slump position (thoracic and lumbar flexion) which they needed to maintain throughout the exercise. This SSLS consisted of alternating movements towards knee extension and ankle dorsiflexion (increase of neural tension) combined with cervical extension (decrease of neural tension) on one hand, and knee flexion and ankle plantar flexion (decrease neural tension) combined with cervical flexion (increase of neural tension) on the other. During this 6-week period, each subject in this neurodynamic slider group was instructed to perform 3 sets of 20 repetitions on a daily basis for 6 weeks.

Active Comparator: Static stretch

Other: Static stretch
Subjects in the control group were instructed to perform a standard standing static stretch with the heel of the dominant leg taking support on a chair. Then they had to move the pelvis into anteversion, simultaneously inducing a forward lean of the trunk, until the clear sensation of hamstring stretch was perceived at the posterior aspect of the thigh. Again, the execution of the exercise was thoroughly explained and evaluated by the researchers and subjects sent home with a comprehensive instruction guide and supporting pictures. Each subject was instructed to do 3 repetitions of 30 second static stretches on a daily basis during the 6-week intervention.

Outcome Measures

Primary Outcome Measures

  1. Hamstring flexibility [at Baseline]

    Straight leg raise by means of an app based goniometer

  2. Hamstring flexibility [6 weeks after intervention]

    Straight leg raise by means of an app based goniometer

  3. Hamstring flexibility [4 weeks after retention period]

    Straight leg raise by means of an app based goniometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • male

  • aged between 18-30yrs

  • recreationally/competitively active

  • limited hamstring flexibility (Tight Hamstring Syndrome) (SLR≤75°)

Exclusion Criteria:
  • a history of any musculotendinous hamstring injury in the previous year

  • a history of neurological or orthopedic disorder affecting the lower extremities

  • a history of lumbar disc herniation; or (4) a history of a cervical whiplash injury

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Ghent

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Ghent
ClinicalTrials.gov Identifier:
NCT05652452
Other Study ID Numbers:
  • B670201630354
First Posted:
Dec 15, 2022
Last Update Posted:
Dec 15, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Dec 15, 2022